[Severe mucormycosis after organ transplantation. Report of a case].
Opportunistic infections remain one of the penalties of the immunosuppression required for successful outcome of organ transplantation. We report the case of a 51 year old woman who, after having received combined kidney and pancreas transplants, developed invasive mucormycosis in the gastrointestinal tract. The hallmarks of successful management of this rare but potentially fatal fungal infection are radical surgical debridement, aggressive antimycotic therapy and control of any underlying diseases. Diagnostic and therapeutic approaches are discussed.
Jørgensen
P F
PF
Kirurgisk avdeling B, Rikshospitalet, Oslo.
Brekke
I B
IB
Bakka
A
A
Clausen
O P
OP
D000935:Antifungal Agents / Q000627:therapeutic use; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D005759:Gastroenteritis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D009336:Necrosis; D016035:Pancreas Transplantation / Q000009:adverse effects*
D000935:Antifungal Agents; D007166:Immunosuppressive Agents
Alvorlig mucormykose etter organtransplantasjon. En kasuistikk.